AMRX 经营现金流历史(2016–2025)
AMNEAL PHARMACEUTICALS, INC. (AMRX) 年度经营现金流历史(来自 SEC 财报)—— 每个财年经营活动产生的现金净额。
$340.0MFY2025 · FY2016 以来:$115.1M → $340.0M
| 财年 | 数值 | 同比 |
|---|---|---|
| FY2025 | $340.0M | +15.2% |
| FY2024 | $295.1M | -14.6% |
| FY2023 | $345.6M | +430.8% |
| FY2022 | $65.1M | -73.1% |
| FY2021 | $241.8M | -36.2% |
| FY2020 | $379.0M | +22128.8% |
| FY2019 | $1.7M | -99.3% |
| FY2018 | $250.2M | +6.9% |
| FY2017 | $234.2M | +103.5% |
| FY2016 | $115.1M | — |
数据来自 SEC XBRL 申报 · 仅供参考 · 非投资建议